Allworth Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.95K Sell
5,072
-1,408
-22% -$2.76K ﹤0.01% 4263
2026
Q2
$15.7K Buy
6,480
+4,304
+198% +$10.5K ﹤0.01% 3383
2026
Q1
$5.16K Buy
2,176
+2,017
+1,269% +$6.99K ﹤0.01% 3943
2025
Q4
$824 Buy
159
+158
+15,800% +$766 ﹤0.01% 4413
2025
Q3
$5 Buy
+1
New +$5 ﹤0.01% 4892
2025
Q2
– Sell
-228
Closed -$1.03K – 4653
2025
Q1
$1.03K Buy
+228
New +$921 ﹤0.01% 3454
2023
Q1
– Sell
-168
Closed -$452 – 3266
2022
Q4
$452 Buy
+168
New +$490 ﹤0.01% 2660

Other funds holding ORGO

Allworth Financial's ORGO Position: Q3 2026 in Review

Allworth Financial reduced its Organogenesis Holdings (ORGO) stake by 22% in Q3 2026, selling an estimated $2.76K and leaving 5,072 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4263.

Allworth Financial first reported a position in ORGO in Q4 2022 and has held it in 7 quarters since. The position peaked at $15.7K in Q2 2026. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • Allworth Financial held 5,072 shares of Organogenesis Holdings worth $6.95K as of Q3 2026.
  • Allworth Financial sold 1,408 Organogenesis Holdings shares in Q3 2026, an estimated $2.76K.
  • Organogenesis Holdings made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4263 holding.
  • Allworth Financial first reported a position in Organogenesis Holdings in Q4 2022 and has held it in 7 quarters since.
  • Allworth Financial's Organogenesis Holdings position peaked at $15.7K in Q2 2026.
  • 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.